APA (7th ed.) Citation

DCF, K., B, B., MNJM, W., S, F. S., IS, I., JSD, M., . . . ME, v. L. (2022). Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(28), 3267. https://doi.org/10.1200/JCO.22.00194

Chicago Style (17th ed.) Citation

DCF, Klatte, et al. "Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 40, no. 28 (2022): 3267. https://doi.org/10.1200/JCO.22.00194.

MLA (9th ed.) Citation

DCF, Klatte, et al. "Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 40, no. 28, 2022, p. 3267, https://doi.org/10.1200/JCO.22.00194.